GEN 004
Alternative Names: GEN-004; Pneumococcal vaccine - Genocea/PATH/Childrens Hospital Boston; Prophylactic Streptococcus pneumoniae vaccine - Genocea Biosciences; Streptococcus… See moreLatest Information Update: 07 Sep 2021
Price :
$50 *
At a glance
- Originator Genocea Biosciences
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Pneumococcal infections
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 28 Oct 2016 Genocea Biosciences plans a phase II trial in Pneumococcal infections (Prevention, In infants, In toddlers)
- 09 Jun 2016 GEN 004 is available for licensing as of 09 Jun 2016
- 05 May 2016 Genocea Biosciences completes a phase II trial in Pneumococcal infections (Prevention in healthy volunteers) in United Kingdom (NCT02116998)